Beranda › Dermatitis Atopik (Eksim) › Washington
Uji klinis Dermatitis Atopik (Eksim) di Washington, DC
11 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Menerima pesertaFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Natural History and Genetics of Food Allergy and Related Conditions
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Menerima pesertaFase 2
- Novartis Investigative Site, Washington D.C.
Effects of Treatments on Atopic Dermatitis
Menerima pesertaFase 2Sukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Cardamom and Topical Roseomonas in Atopic Dermatitis
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Menerima pesertaFase 3
- Maryland Allergy & Asthma Center /ID# 268032, Lanham · 11 mi jauhnya
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Menerima pesertaStudi observasional
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Menerima pesertaStudi observasional
- Galderma Investigational Site 8012, Glenn Dale · 13 mi jauhnya
Uji klinis Dermatitis Atopik (Eksim) di kota lain
- New York City, NY13 studi
- Los Angeles, CA11 studi
- San Antonio, TX10 studi
- San Diego, CA10 studi
- Birmingham, AL9 studi
- Miami, FL9 studi
- Dallas, TX8 studi
- Sacramento, CA8 studi
- Huntington Beach, CA8 studi
- Troy, MI8 studi
- Indianapolis, IN7 studi
- Pittsburgh, PA7 studi
Studi lain di Washington
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil55 studi
- Kanker Payudara46 studi
- Kanker Metastatik43 studi
- Kanker Paru41 studi
- Kanker Prostat38 studi
- Obesitas33 studi
- Kanker Kolorektal29 studi
- Penyakit Kardiovaskular28 studi
- Kanker Kandung Kemih26 studi
- Leukemia Mieloid Akut24 studi
- Kanker Ovarium23 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.